Elevance Health
ELV
ELV
907 hedge funds and large institutions have $50.8B invested in Elevance Health in 2017 Q4 according to their latest regulatory filings, with 138 funds opening new positions, 267 increasing their positions, 359 reducing their positions, and 65 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
907
Holders Change
+65
Holders Change %
+7.72%
% of All Funds
20.6%
Holding in Top 10
33
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+17.86%
% of All Funds
0.75%
New
138
Increased
267
Reduced
359
Closed
65
Calls
$146M
Puts
$349M
Net Calls
-$203M
Net Calls Change
-$40.4M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$544M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$374M |
| 3 |
JPMorgan Chase & Co
New York
|
+$204M |
| 4 |
Goldman Sachs
New York
|
+$204M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$195M |
Top Sellers
| 1 |
EIG
EdgePoint Investment Group
Toronto,
Ontario, Canada
|
-$238M |
| 2 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$209M |
| 3 |
TP
Third Point
New York
|
-$197M |
| 4 |
BlackRock
New York
|
-$176M |
| 5 |
GCM
Glenview Capital Management
New York
|
-$168M |
